Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)
Clinical trial NCT06152237 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06152237
- Sponsor
- Taysha Gene Therapies, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2028-11-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.